A PHASE-II STUDY OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA

被引:235
作者
DUTCHER, JP
CREEKMORE, S
WEISS, GR
MARGOLIN, K
MARKOWITZ, AB
ROPER, M
PARKINSON, D
CIOBANU, N
FISHER, RI
BOLDT, DH
DOROSHOW, JH
RAYNER, AA
HAWKINS, M
ATKINS, M
机构
[1] LOYOLA UNIV,MED CTR,MAYWOOD,IL 60153
[2] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[3] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[4] NCI,BETHESDA,MD 20205
[5] TUFTS UNIV,NEW ENGLAND MED CTR,BOSTON,MA 02111
[6] MONTEFIORE MED CTR,ALBERT EINSTEIN CANC CTR,NCI,IL2LAK EXTRAMURAL WORKING GRP,BRONX,NY 10467
[7] CITY HOPE CANC RES CTR,DUARTE,CA
关键词
D O I
10.1200/JCO.1989.7.4.477
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:477 / 485
页数:9
相关论文
共 25 条
[1]   HYPOTHYROIDISM AFTER TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS [J].
ATKINS, MB ;
MIER, JW ;
PARKINSON, DR ;
GOULD, JA ;
BERKMAN, EM ;
KAPLAN, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (24) :1557-1563
[2]  
BOLDT DH, 1988, CANCER RES, V48, P4409
[3]  
COHEN PJ, 1987, AM J PATHOL, V129, P208
[4]  
CREAGAN ET, 1986, CANCER TREAT REP, V70, P619
[5]  
DUTCHER JP, 1987, P AN M AM SOC CLIN, V6, P246
[6]  
FAIRMAN RP, 1987, CANCER RES, V47, P3528
[7]   METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].
FISHER, RI ;
COLTMAN, CA ;
DOROSHOW, JH ;
RAYNER, AA ;
HAWKINS, MJ ;
MIER, JW ;
WIERNIK, P ;
MCMANNIS, JD ;
WEISS, GR ;
MARGOLIN, KA ;
GEMLO, BT ;
HOTH, DF ;
PARKINSON, DR ;
PAIETTA, E .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523
[8]  
HANAFUSA T, 1983, LANCET, V2, P1111
[9]  
HELLSTROM I, 1968, NATURE, V330, P1352
[10]  
JANSSON R, 1984, CLIN EXP IMMUNOL, V58, P264